Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Colomer

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 28, 2007
Current controversies in the management of early breast cancerL G Estévez, M Martín, E Alba, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 13, 2021
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidinesP García-Alfonso, M Saiz-Rodríguez, R Mondéjar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 1998
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomizationR Arranz, P García-Alfonso, P Sobrino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2019
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patientsJ Rogado, J M Sánchez-Torres, N Romero-Laorden, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panelM Aapro, P A Abrahamsson, J J Body, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Current controversies in the management of breast cancerI Tusquets, L García-Estévez, E Adrover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)R Colomer, E Alba, A González-Martin, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 28, 2007
Current controversies in the management of early breast cancerL G Estévez, M Martín, E Alba, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 13, 2021
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidinesP García-Alfonso, M Saiz-Rodríguez, R Mondéjar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 1998
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomizationR Arranz, P García-Alfonso, P Sobrino, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2019
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patientsJ Rogado, J M Sánchez-Torres, N Romero-Laorden, et al.
The European Respiratory Journal|July 3, 2010
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutationR Porta, J M Sánchez-Torres, L Paz-Ares, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2007
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panelM Aapro, P A Abrahamsson, J J Body, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2010
Current controversies in the management of breast cancerI Tusquets, L García-Estévez, E Adrover, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerJ Albanell, A González, M Ruiz-Borrego, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2010
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)R Colomer, E Alba, A González-Martin, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
Pageof 10